NR 586NP Week 7 Discussion

Describe one health policy related to an identified health risk or disparity. One significant health policy addressing a health risk is the National HIV/AIDS Strategy (NHAS) in the United States. NHAS was developed to combat the HIV epidemic by focusing on prevention, treatment, and care for individuals living with HIV/AIDS, with particular attention to populations disproportionately affected by the disease, such as racial and ethnic minorities, men who have sex with men (MSM), and transgender individuals. Summarize the intended impact of the policy on the risk or disparity. The NHAS aims to achieve several key outcomes, including reducing new HIV infections, improving health outcomes for people living with HIV/AIDS, and reducing HIV-related health disparities. It emphasizes early diagnosis, linkage to care, retention in care, and adherence to treatment as critical strategies to achieve these goals. By focusing resources and efforts on vulnerable populations, NHAS seeks to mitigate disparities in HIV incidence and health outcomes. Examine the policy within the context of a national population health initiative and determine the degree to which the policy is congruent with that national population health goal and/or objective. NHAS aligns closely with the Healthy People initiative, which includes objectives related to reducing the number of new HIV infections, increasing access to care and treatment for HIV- positive individuals, and reducing HIV-related health disparities. Healthy People 2030 specifically targets achieving health equity and eliminating disparities, making NHAS a crucial component in advancing these objectives by addressing HIV disparities among diverse populations. Propose one strategy to address the health risk or disparity. To enhance the impact of NHAS and mitigate persistent health disparities related to HIV/AIDS, one effective strategy is to expand access to Pre-Exposure Prophylaxis (PrEP). PrEP is a highly effective preventive medication for individuals at high risk of HIV infection. This strategy would involve increasing awareness, availability, and affordability of PrEP through targeted education and outreach campaigns aimed at healthcare providers and at-risk populations. Additionally, advocating for policies to reduce out-of-pocket costs, such as expanding Medicaid coverage and negotiating lower drug prices, would help remove financial barriers to accessing PrEP. Integrating PrEP prescribing into routine primary care settings would further streamline access and ensure more seamless provision of HIV prevention services. By implementing these measures, policymakers can bolster NHAS's effectiveness in reducing new HIV infections and advancing efforts to eliminate HIV-related health disparities in the United States. Reference Office of National AIDS Policy. (2015). National HIV/AIDS strategy for the United States: Updated to 2020. Retrieved from https://files.hiv.gov/s3fs-public/nhas-update.pdf Smith, J. A., & Johnson, B. M. (2020). Health policy responses to HIV/AIDS disparities: A comparative analysis of national strategies. Journal of Public Health Policy, 41(3), 320- 335. https://doi.org/10.1057/s41271-020-00231-4